The World Health Organization on Tuesday approved a tenth COVID-19 vaccine for emergency use.
The global health agency added Nuvaxovid, also known as NVX-CoV2373, to its emergency use listing following an approval from the European Medicines Agency (EMA).
The new vaccine was developed by Maryland-based biotech company Novavax and the ...
from The Washington Times stories: Health https://ift.tt/3J92OWp